Copy number and gene expression differences between African American and Caucasian American prostate cancer
Open Access
- 22 July 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 8 (1), 70
- https://doi.org/10.1186/1479-5876-8-70
Abstract
Background The goal of our study was to investigate the molecular underpinnings associated with the relatively aggressive clinical behavior of prostate cancer (PCa) in African American (AA) compared to Caucasian American (CA) patients using a genome-wide approach. Methods AA and CA patients treated with radical prostatectomy (RP) were frequency matched for age at RP, Gleason grade, and tumor stage. Array-CGH (BAC SpectralChip2600) was used to identify genomic regions with significantly different DNA copy number between the groups. Gene expression profiling of the same set of tumors was also evaluated using Affymetrix HG-U133 Plus 2.0 arrays. Concordance between copy number alteration and gene expression was examined. A second aCGH analysis was performed in a larger validation cohort using an oligo-based platform (Agilent 244K). Results BAC-based array identified 27 chromosomal regions with significantly different copy number changes between the AA and CA tumors in the first cohort (Fisher's exact test, P < 0.05). Copy number alterations in these 27 regions were also significantly associated with gene expression changes. aCGH performed in a larger, independent cohort of AA and CA tumors validated 4 of the 27 (15%) most significantly altered regions from the initial analysis (3q26, 5p15-p14, 14q32, and 16p11). Functional annotation of overlapping genes within the 4 validated regions of AA/CA DNA copy number changes revealed significant enrichment of genes related to immune response. Conclusions Our data reveal molecular alterations at the level of gene expression and DNA copy number that are specific to African American and Caucasian prostate cancer and may be related to underlying differences in immune response.Keywords
This publication has 32 references indexed in Scilit:
- Results from a Phase I Clinical Study of the Novel Ii-Key/HER-2/neu(776–790) Hybrid Peptide Vaccine in Patients with Prostate CancerClinical Cancer Research, 2010
- Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-AmericansBJU International, 2010
- Integrated data from 2 randomized, double‐blind, placebo‐controlled, phase 3 trials of active cellular immunotherapy with sipuleucel‐T in advanced prostate cancerCancer, 2009
- Microarray comparison of prostate tumor gene expression in African-American and Caucasian American males: a pilot project studyInfectious Agents and Cancer, 2009
- Impact of Socioeconomic Factors on Prostate Cancer Outcomes in Black Patients Treated with SurgeryUrology, 2008
- Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarrayThe Prostate, 2008
- Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American MenCancer Research, 2008
- Genetic aberrations in prostate cancer by microarray analysisInternational Journal of Cancer, 2006
- Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinomaCancer, 2006
- Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groupsGenomics, 1992